Upfront therapy with allogeneic hematopoietic stem cell transplantation versus DNA methyltransferase inhibitors in patients with vexas syndrome: A comparative matched cohort efficacy analysis of 39 patients
Saubia Fathima(Mayo Clinic), Abhishek A. Mangaonkar(Mayo Clinic), Mithun Vinod Shah(Mayo Clinic in Arizona), Horatiu Olteanu(Mayo Clinic in Arizona), Urshila Durani(Mayo Clinic), Saurabh Chhabra(Medical College of Wisconsin), Ronald S. Go(Mayo Clinic), Mary Riwes(University of Michigan), Terra Lasho(Mayo Clinic), Ali Alsugair(Mayo Clinic in Arizona), Aasiya Matin(Mayo Clinic in Arizona), Jade L. Kutzke(Mayo Clinic), Kenneth J. Warrington(Mayo Clinic), Joseph P. McGuirk(University of Kansas Medical Center), Amelia Langston(CancerCare Manitoba), Jeanne Palmer(Mayo Clinic), Hassan B. Alkhateeb(Mayo Clinic), Yael Kusne(WinnMed), Mehrdad Hefazi(Mayo Clinic), Elizabeth F. Krakow(Fred Hutch Cancer Center), Mrinal M. Patnaik(Mayo Clinic), Gabriel Bartoo(Mayo Clinic), Taxiarchis Kourelis(Mayo Clinic in Arizona), Kristen McCullough(Mayo Clinic), Christy M. Finke(Mayo Clinic), William J. Hogan(Mayo Clinic), Kaaren K. Reichard(Mayo Clinic), Mark R. Litzow(Mayo Clinic in Arizona), David Dingli, Kimberly J. Langer(Mayo Clinic), Matthew J. Koster(Mayo Clinic in Arizona)
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907